Six-Week Open-Label Reboxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
by
Ratner S, Laor N, Bronstein Y, Weizman A, Toren P.
Drs. Ratner, Laor, Bronstein, and Toren are with the Tel Aviv-Brull Community Mental Health Center, Israel;
Dr. Weizman is with the Geha Mental Health Center and the Felsenstein Medical Research Center, Petah Tiqva, Israel;
Drs. Laor, Weizman, and Toren are with the Sackler Faculty of Medicine, Tel Aviv University;
Dr. Laor is with the Yale Child Study Center, New Haven, CT.
J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):428-433


ABSTRACT

OBJECTIVE:: This open-label study assessed the effectiveness of reboxetine, a selective norepinephrine reuptake inhibitor, in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) resistant to a previous methylphenidate trial. METHOD:: Thirty-one child and adolescent outpatients, aged 8 to 18 (mean age, 11.7; SD = 2.87) years, diagnosed with ADHD were enrolled in a 6-week open-label study. Assessments included rater-administered scales (DSM-IV ADHD Scale; Clinical Global Impressions Scale), parent-administered scales (the Abbreviated Conners Rating Scale), and self-administered-scales for the evaluation of depressive (Children's Depression Inventory) and anxiety (the Revised Children's Manifest Anxiety Scale) symptoms. Reboxetine was initiated and maintained at a dose of 4 mg/day. RESULTS:: A significant decrease in ADHD symptoms, on all scales measured, was noted. Adverse effects were relatively mild and transient. The most common adverse effects were drowsiness/sedation and gastrointestinal complaints. CONCLUSIONS:: The results of the current open-label study suggest the effectiveness of reboxetine in the treatment of ADHD in methylphenidate-resistant children and adolescents. Double-blind, placebo-, and active comparator-controlled studies are indicated to rigorously test the efficacy of reboxetine in ADHD.

ADHD
Switching from Prozac
Reboxetine: product info
Noradrenergic antidepressants
Noradrenaline and cerebral aging
Reboxtine versus fluoxetine (Prozac)



Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family